| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 25N106WEDO |
| InChI Key | OTFDPNXIVHBTKW-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H25ClN2O4S |
| Molecular Weight | 364.9 |
| AlogP | 1.17 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 75.71 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 22.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 106 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Huntington Disease | 3 | D006816 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 32220 |
| ChEMBL | CHEMBL1256772 |
| EPA CompTox | DTXSID4045210 |
| FDA SRS | 25N106WEDO |
| PubChem | 39855 |
| SureChEMBL | SCHEMBL355315 |